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The increasing proportion of lung cancers classiﬁed as adenocarcinoma has been a topic of interest and
research. The main objective of the analyses reported here is to summarize how the proportion of
adenocarcinoma varies in never smokers by time, sex and region based on published evidence on the
distribution of lung cancer types available from epidemiological studies. Based on 219 sex- and period-
speciﬁc blocks of data drawn from 157 publications, there appears to be a clear time-related increase in
the proportion of lung cancers in never smokers that are adenocarcinoma, which is evident in both sexes,
and not speciﬁc to any region. It is seen whether the denominator of the proportion is made up of
adenocarcinoma plus squamous cell carcinoma cases, cases of the four major types combined, or all lung
cancer cases. The ratio of adenocarcinoma to squamous cell carcinoma rose continuously from 1950 to 69
to be almost 4 times higher for the data from 2000 onwards. We discuss factors that may have
contributed to the observed ﬁndings, including changes in lung cancer classiﬁcation. Our ﬁndings argue
against the hypothesis that increases in the ratio arise from changes in cigarette design and composition.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The risk of developing lung cancer is strongly associated with
cigarette smoking. In general, lung cancer trends tend to lag behind,
but reﬂect trends in cigarette smoking prevalence (Devesa et al.,
2005). In the United States, overall lung cancer mortality rates
have been declining since 1990 (US Surgeon General, 2014). While
smoking is associated with all the major histological types of lung
cancer, the association varies by type. A recent meta-analysis of
epidemiological evidence in the 1900s relating smoking to lung
cancer (Lee et al., 2012) reported relative risks (RRs) in current
smokers of 18.17 (95% conﬁdence interval [CI] 12.92e25.56) forhioloalveolar carcinoma; CI,
Smoking and Lung Cancer;
cinoma; SqCC, squamous cell
mputing Ltd, 17 Cedar Road,
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Inc. This is an open access article usmall cell carcinoma (SmCC), 16.43 (12.66e21.32) for squamous cell
carcinoma (SqCC), 8.56 (5.29e13.86) for large cell carcinoma (LgCC)
and 4.05 (3.15e5.22) for adenocarcinoma (AdC). For ex smokers,
RRs were again higher for SqCC (8.74, 6.94e11.01) than for AdC
(2.85, 2.20e3.70).
Time trends in lung cancer rates also vary by histological type
(Devesa et al., 2005). In particular, trends in the frequency of AdC
relative to SqCC have become a topic of interest and research
(Wingo et al., 1999). In the late 1950s, SqCC was the dominant lung
cancer type in US men, with the prevalence of AdC relatively minor
by comparison (Thun et al., 1997). Over the following decades, data
in the SEER tumour registries (which started in 1973), indicated
that the prevalence of AdC relative to SqCC rose sharply so that, by
the late 1980s, the prevalence of AdC had exceeded that of SqCC
thus becoming the dominant lung cancer type in men (Thun and
Heath, Jr., 1997). In women, AdC has been the dominant form of
lung cancer throughout the period of data collection in the SEER
registries (US Surgeon General, 2014).
The aetiological factors inﬂuencing the apparent shifts in the
relative proportions of AdC vs. SqCC of the lung are complex and
not clearly understood (Lewis et al., 2014). One hypothesis suggests
that changes in the design and composition of cigarettes to reducender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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in absolute terms, and relative to SqCC (Burns et al., 2011). This
hypothesis has been questioned, however, based on the observa-
tion that the increasing rate of AdC relative to SqCC preceded the
widespread use of low tar cigarettes (Chen et al., 2007b).
Changes in the distribution of smoking habits also affect the
relative frequency of AdC. The pattern of RRs by histological type
cited above suggests that the relative frequency of AdC to SqCC
would increase as the proportion of current smokers in the popu-
lation decreases, either due to an increase in smoking cessation or a
reduction in initiation. This increase would, however, not be large.
For example, based on these RRs one can readily calculate (details
available on request) that the relative frequency of AdC to SqCC
would only be 8% higher for a population with equal numbers of
current smokers, ex-smokers and never smokers than for a popu-
lation with 50% current smokers, 25% ex-smokers and 25% never
smokers.
There is also evidence that non-smoking related factors have
inﬂuenced the changing patterns of these two types of lung cancer.
Although the majority of lung cancer mortality in the United States
has been attributed to cigarette smoking, Samet et al. (2009) esti-
mated that 10%e15% of lung cancer deaths are accounted for by
non-smoking related factors. They also noted that, in men, the rate
of AdC is increasing, whereas that of SqCC is decreasing even in
never smokers. Likewise, in a meta-analysis which estimated rates
among never smokers indirectly by combining data from national
rates and epidemiological studies, a clear increase in rates of AdC
over time was noted, with little change in rates of SqCC (Lee and
Forey, 2013).
Changes in the histological classiﬁcation of lung tumours may
have inﬂuenced time trends in the AdC/SqCC ratio. Thus, some
studies (Campobasso et al., 1993; Greenberg et al., 1984; Vincent
et al., 1977; Yesner et al., 1973) found a signiﬁcant increase in the
numbers of AdC when the diagnoses of histological type originally
made some years earlier were reviewed, though others (Butler
et al., 1987, Brownson et al., 1995) did not. Also, a number of
studies that used standard criteria to review cases collected over at
least a 10 year period (mean 21 years) found no evident increase in
the proportion of lung cancers classiﬁed as AdC (Auerbach et al.,
1975; Beard et al., 1988; Butler et al., 1987; Caldwell and Berry,
1996; Chan and Maclennan, 1977; Kennedy, 1973; Tanaka et al.,
1988), although a few showed some increase (Andrews, Jr. et al.,
1985; Valaitis et al., 1981; Wahbah et al., 2007).
A fundamental question that could shed light on the underlying
factors inﬂuencing observed rates of these two lung cancer types is
whether the temporal patterns of the relative proportions of AdC
vs. SqCC of the lung are similar in never smokers compared with
smokers. The main objective of the analyses reported here is to
summarize how the proportion of AdC varies in never smokers by
time, sex and region based on published evidence on the distri-
bution of lung cancer types available from epidemiological studies.
2. Methods
2.1. Inclusion and exclusion criteria
The analyses reported here are part of a wider project intended
to answer three questions: “Has the frequency of AdC increased
over time, and particularly has it increased in never smokers?”,
“Has the classiﬁcation and diagnosis of histological type changed
over time, so as to result in an artefactual rise in the frequency of
reported AdC?”, and “What risk factors other than smoking are
there for AdC?” The present report addresses the ﬁrst question,
speciﬁcally with respect to AdC as a proportion of all lung cancers in
never smokers.For the present report, there was no restriction on location of
the study. The types of epidemiological study expected to provide
relevant data were case-control, prospective or cross-sectional,
though other types would be considered if found. Inclusion
criteria were the following: studies must report the distribution of
lung cancer type in never smokers (or near-equivalent as deﬁned
elsewhere (Lee et al., 2012)); studies conducted from 1940; and
studies of at least 20 lung cancer cases in never smokers. Exclusion
criteria were: histological typing assessed at a time more than ﬁve
years after death/diagnosis; distribution of histological type only
available for a period more than 10 years long (the objective being
to relate distributions to time); subjects sampled by histological
type; study restricted to speciﬁc histological types, unless it
included cases with at least the four main types of lung cancer
(SqCC, SmCC, AdC, LgCC); study did not report AdC separately;
study of persons at high risk of respiratory disease or with other co-
existing diseases or conditions, or of other clearly atypical pop-
ulations; and study of children or adolescents.
2.2. Literature searching and screening methods
In the initial phase, papers were extracted from a variety of in-
house ﬁles, including those used for projects on the International
Evidence on Smoking and Lung Cancer (IESLC) (Lee et al., 2012), on
Environmental Tobacco Smoke and Lung Cancer (Lee et al., 2014), or
for an earlier uncompleted similar project in 2002, and also those
keyworded in our ﬁles as referring to lung cancer diagnosis or
histological type, or as referring to risk of lung cancer from smok-
ing. Secondary references (relevant papers cited in initial publica-
tions), and in some cases tertiary references (relevant papers cited
in secondary references) were also sought.
Except for some papers previously identiﬁed in IESLC as having
no histological conﬁrmation, each paper was read and assessed in
respect of all three questions by PNL, BAF and/or KJC. Where the
assessor was in doubt about the relevance of a paper to one of the
questions, other assessor(s) were consulted and a consensus deci-
sion reached. Review papers were reconsidered at the end, to
ensure that any data cited were extracted if the originally cited
paper had proved unavailable. For each paper rejected, a reason for
rejection code was assigned. The reasons applicable to lung cancer
trends in never smokers were divided into ﬁve groups: immediate
rejects; publication does not provide original data; study design or
outcome inappropriate; study population inappropriate; and no
useful results.
Subsequently, on April 30th 2015, a Medline search was con-
ducted using the search term (“lung neoplasms” [MeSH Terms] OR
(“lung” [All Fields] AND “neoplasms” [All Fields]) OR “lung neo-
plasms” [All Fields] OR (“lung” [All Fields] AND “cancer” [All Fields])
OR “lung cancer” [All Fields]) AND never [All Fields] AND (smoker
[All Fields] OR “smoking” [MeSH Terms] OR “smoking” [All Fields]
OR “tobacco products” [MeSH Terms] OR (“tobacco” [All Fields]
AND “products” [All Fields]) OR “tobacco products” [All Fields] OR
“cigarette” [All Fields]) AND (histologic [All Fields] OR histological
[All Fields] OR (“adenocarcinoma” [MeSH Terms] OR “adenocarci-
noma” [All Fields]) OR squamous [All Fields]), and papers not
already identiﬁed in the initial phase were assessed using the same
inclusion/exclusion criteria to determine their relevance to study of
lung cancer trends in never smokers.
2.3. Data extraction
For each paper accepted, a separate block of data was extracted
for each sex, country and period for which results were available.
Data for the sexes combined were extracted only when sex-speciﬁc
data were not available. Data were not extracted by age or race, but
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giving duplicate or superseded data were omitted. For each block,
the ﬁelds relevant to lung cancer trends in never smokers were as
follows: study identiﬁcation code, country, locationwithin country,
age range, race, other population description (e.g. farmers), study
type, sex, deﬁnition of never smoking, start and end years of period,
classiﬁcation system used for histological type, whether the deﬁ-
nition of AdC includes bronchioloalveolar carcinoma (BALC) or not,
case selection (e.g. all, autopsy, histology [including cytology where
stated]), total cases with histological types, lung cancer types
excluded, number and percentage of cases by type (if necessary,
numbers being calculated from percentages, or vice versa), deﬁni-
tion of “other” histological type, source of data (Table, Figure or
page numbers as appropriate), availability of data by age, and by
race, and any general comments.
2.4. Identiﬁcation of overlapping data
Although some attempt had been made during literature
searching and data extraction to reject papers that presented data
already reported elsewhere or superseded by a later paper, further
attempts to avoid double counting of the same lung cancer cases
were made following data extraction. Blocks of data extracted were
sorted by location and study period and overlapping studies were
identiﬁed, and a decision made, based on the detail of the data
provided, as to which would provide the data to be used for each
analysis. This maymean totally ignoring data from a publication, or
only using its data for speciﬁc analyses.
2.5. Analysis
As noted above, attention was already limited to studies based
on at least 20 cases in never smokers. Where sex- or time-speciﬁc
results were available, we further restricted attention to blocks
with 10 cases. The blocks were separated into three categories
(males, females, sexes combined), six time-periods (midpoint of the
period reported 1950e59, 1960e69, 1970e79, 1980e89, 1990e99
and 2000þ), and ﬁve regions (USA, Europe, China, Japan, other orTable 1
Reasons for rejection.
Number of rejections Reason
Immediate rejects
13 Paper not already in-house, no abstract a
27 Paper could not be obtained (or translate
Publication does not provide original d
143 Results same as, or superseded by, anoth
44 Case report
259 No original data
Study design/outcome inappropriate
15 Animal, in vitro or ecological study, or th
181 Not a study of lung cancer
4 Study of treatment, survival, prognosis et
125 IESLC study previously noted as having 0
980 Only overall lung cancer, not by type
459 Cases selected on histological type, or no
12 Selection of subjects not clearly described
150 Study too small (<100 overall cases, < 20
47 Adenocarcinoma not reported as a separa
Study population inappropriate
31 Study in population at high risk of lung c
11 Study of subjects with other coexisting d
5 Study of atypical populations
41 Subjects inappropriately selected on smo
No useful results
116 No distribution by histological type
637 No never smoker results based on 20 þ c
163 Reported period(s) > 10 years, diagnosesmulti-country). Note that sexes combined relates only to studies
where results were unavailable by sex, and that results for 1950e59
and 1960e69 were combined in some analyses due to the small
number of blocks for those periods.
Three proportions of AdC were considered in analysis: as a
proportion of AdC plus SqCC (P1), as a proportion of all cases (P2),
and as a proportion of the four major types, SqCC, SmCC, AdC and
LgCC (P3). Other types of lung cancer contributing to the all cases
data included adenosquamous carcinoma, carcinoid tumours,
bronchial gland carcinomas and other rarer types, though the fre-
quency of these was rarely given in the source papers. Note that
each block does not necessarily provide the relevant data for each
analysis. Thus, the source publication may only provide numbers of
total and AdC cases, only allowing estimation of P2, or SmCC and
LgCC may be combined with cancers not of the major types, ruling
out estimation of P3.
Meta-analyses were carried out based on the method of DerSi-
monian and Laird (DerSimonian and Laird, 1986) using the double
arc sine transformation to convert the properties to a normally
distributed scale (Freeman and Tukey,1950;Miller,1978). In viewof
the considerable heterogeneity, only results of random-effects
meta-analyses are reported.
In addition, analyses were carried on the proportions of cell
types other than AdC. The cell types considered were SqCC, SmCC,
LgCC, Other 1 (not SqCC, SmCC, LgCC or AdC) and Other 2 (not AdC
or SqCC). These are expressed as proportions of total cases. Here,
results are shown overall and by time.
3. Results
3.1. Literature searches
In the initial phase, 3134 papers were considered. After elimi-
nating duplicates and superseded papers and checking the provi-
sionally accepted papers in more detail, 142 were eventually
considered relevant for the study of AdC trends in never smokers as
a proportion of all lung cancers. The Medline search identiﬁed 497
new papers of which an additional 26 were considered relevant.vailable on Medline and title of the paper clearly indicates it is irrelevant
d)
ata
er publication
eoretical modelling exercise
c.
% histological conﬁrmation
t including the four main types
, and may be non-random or inappropriate
in never smokers)
te group, e.g. studies reporting only Kreyberg I vs II, or only squamous vs. others
ancer or respiratory diseases (e.g. risky occupations)
iseases or conditions
king habits
ases
reviewed >5 years after death/diagnosis, study before 1940
Table 2
Random-effects meta-analyses of P1, the proportion of AdC out of AdC þ SqCC.
95% conﬁdence limits Between levels
Sex Region Period Blocks Mean Lower Upper Chisq per DF p
All All All 176 0.80 0.77 0.82
All All 1950e59 3 0.48 0.26 0.70
1960e69 6 0.70 0.48 0.89
1970e79 21 0.74 0.67 0.81
1980e89 49 0.77 0.72 0.82
1990e99 58 0.80 0.76 0.84
2000þ 39 0.87 0.85 0.90
7.68 ***
All All 1950e69 9 0.63 0.46 0.78
1970e79 21 0.74 0.67 0.81
1980e89 49 0.77 0.72 0.82
1990e99 58 0.80 0.76 0.84
2000þ 39 0.87 0.85 0.90
8.27 ***
Males All All 52 0.73 0.67 0.78
Females 84 0.82 0.79 0.84
Combined 40 0.83 0.79 0.88
5.68 **
All US All 45 0.80 0.75 0.85
Europe 48 0.73 0.68 0.78
China 25 0.81 0.76 0.84
Japan 22 0.88 0.81 0.93
Other 36 0.81 0.76 0.85
3.79 **
Males All 1950e69 2 0.69 0.01 0.95
1970e79 9 0.61 0.50 0.71
1980e89 19 0.70 0.61 0.78
1990e99 14 0.76 0.62 0.88
2000þ 8 0.86 0.82 0.91
6.98 ***
Females All 1950e69 7 0.63 0.50 0.76
1970e79 11 0.81 0.74 0.86
1980e89 25 0.83 0.78 0.87
1990e99 26 0.81 0.76 0.86
2000þ 15 0.86 0.82 0.90
3.78 **
Combined All 1970e79 1 0.93 0.80 1.00
1980e89 5 0.64 0.47 0.80
1990e99 18 0.82 0.75 0.88
2000þ 16 0.89 0.84 0.93
4.19 **
All US 1950e69 7 0.69 0.51 0.85
1970e79 6 0.73 0.55 0.88
1980e89 18 0.79 0.70 0.87
1990e99 9 0.906 0.86 0.94
2000þ 5 0.902 0.88 0.92
5.25 ***
All Europe 1950e69 2 0.36 0.18 0.55
1970e79 4 0.67 0.50 0.82
1980e89 7 0.68 0.57 0.79
1990e99 22 0.73 0.65 0.81
2000þ 13 0.80 0.74 0.85
5.84 ***
All China 1970e79 3 0.73 0.65 0.81
1980e89 9 0.74 0.66 0.81
1990e99 5 0.80 0.70 0.88
2000þ 8 0.88 0.85 0.92
7.33 ***
All Japan 1970e79 2 0.73 0.49 0.92
1980e89 10 0.81 0.67 0.91
1990e99 6 0.95 0.93 0.97
2000þ 4 0.96 0.90 0.99
4.75 **
All Other 1970e79 6 0.80 0.69 0.90
1980e89 5 0.75 0.56 0.90
1990e99 16 0.78 0.72 0.83
2000þ 9 0.89 0.84 0.93
3.32 *
Note that lines with no available blocks are omitted, and that signiﬁcant heterogeneity by the factor studied (period, sex or region) is indicated by (*) p < 0.1, *p < 0.05,
**p < 0.01 and ***p < 0.001. NS indicates p  0.1.
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Table 3
Random-effects meta-analyses of P2, the proportion of AdC out of the total number of cases.
95% conﬁdence limits Between levels
Sex Region Period Blocks Mean Lower Upper Chisq per DF p
All All All 182 0.59 0.56 0.62
All All 1950e59 7 0.32 0.22 0.44
1960e69 6 0.41 0.21 0.63
1970e79 15 0.48 0.37 0.59
1980e89 42 0.54 0.48 0.60
1990e99 58 0.62 0.59 0.66
2000þ 54 0.67 0.63 0.72
9.17 ***
All All 1950e69 13 0.36 0.25 0.47
1970e79 15 0.48 0.37 0.59
1980e89 42 0.54 0.48 0.60
1990e99 58 0.62 0.59 0.66
2000þ 54 0.67 0.63 0.72
9.14 ***
Males All All 53 0.51 0.45 0.57
Females 83 0.62 0.59 0.65
Combined 46 0.61 0.56 0.67
4.96 **
All US All 48 0.55 0.50 0.61
Europe 52 0.52 0.48 0.57
China 25 0.62 0.56 0.68
Japan 22 0.77 0.70 0.83
Other 35 0.59 0.53 0.65
9.69 ***
Males All 1950e69 3 0.38 0.03 0.82
1970e79 7 0.36 0.24 0.50
1980e89 17 0.46 0.38 0.54
1990e99 14 0.59 0.54 0.65
2000þ 12 0.64 0.56 0.71
4.89 ***
Females All 1950e69 8 0.42 0.33 0.51
1970e79 7 0.62 0.52 0.72
1980e89 21 0.61 0.55 0.67
1990e99 27 0.63 0.57 0.68
2000þ 20 0.69 0.62 0.75
5.56 ***
Combined All 1950e69 2 0.20 0.14 0.26
1970e79 1 0.29 0.20 0.39
1980e89 4 0.46 0.32 0.60
1990e99 17 0.64 0.57 0.70
2000þ 22 0.68 0.60 0.75
29.54 ***
All US 1950e69 10 0.41 0.28 0.56
1970e79 4 0.46 0.16 0.77
1980e89 18 0.55 0.46 0.64
1990e99 11 0.64 0.61 0.67
2000þ 5 0.70 0.60 0.80
3.85 **
All Europe 1950e69 3 0.20 0.14 0.26
1970e79 4 0.44 0.24 0.64
1980e89 7 0.44 0.33 0.54
1990e99 20 0.55 0.50 0.60
2000þ 18 0.59 0.52 0.65
20.51 ***
All China 1970e79 1 0.55 0.43 0.67
1980e89 7 0.52 0.44 0.60
1990e99 6 0.67 0.56 0.77
2000þ 11 0.67 0.56 0.77
2.42 (*)
All Japan 1970e79 2 0.63 0.41 0.82
1980e89 5 0.69 0.48 0.87
1990e99 8 0.80 0.74 0.85
2000þ 7 0.84 0.78 0.89
1.98 NS
All Other 1970e79 4 0.42 0.28 0.56
1980e89 5 0.50 0.34 0.67
1990e99 13 0.58 0.52 0.64
2000þ 13 0.68 0.57 0.78
3.10 *
Note that lines with no available blocks are omitted, and that signiﬁcant heterogeneity by the factor studied (period, sex or region) is indicated by (*) p < 0.1, *p < 0.05,
**p < 0.01 and ***p < 0.001. NS indicates p  0.1.
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Table 4
Random-effects meta-analyses of P3, the proportion of AdC out of the four major lung cancer types.
95% conﬁdence limits Between levels
Sex Region Period Blocks Mean Lower Upper Chisq per DF p
All All All 100 0.69 0.65 0.72
All All 1950e59 2 0.45 0.11 0.83
1960e69 2 0.36 0.14 0.61
1970e79 17 0.65 0.60 0.71
1980e89 35 0.62 0.56 0.67
1990e99 26 0.75 0.69 0.80
2000þ 18 0.82 0.77 0.86
8.23 ***
All All 1950e69 4 0.41 0.21 0.63
1970e79 17 0.65 0.60 0.71
1980e89 35 0.62 0.56 0.67
1990e99 26 0.75 0.69 0.80
2000þ 18 0.82 0.77 0.86
9.82 ***
Males All All 31 0.60 0.52 0.67
Females 51 0.72 0.68 0.76
Combined 18 0.74 0.66 0.81
4.62 **
All US All 33 0.70 0.65 0.74
Europe 21 0.62 0.54 0.69
China 12 0.73 0.64 0.81
Japan 13 0.76 0.65 0.86
Other 21 0.68 0.59 0.77
1.67 NS
Males All 1970e79 6 0.55 0.50 0.60
1980e89 15 0.51 0.40 0.63
1990e99 6 0.64 0.53 0.75
2000þ 4 0.81 0.65 0.93
3.83 **
Females All 1950e69 3 0.48 0.25 0.70
1970e79 11 0.69 0.64 0.74
1980e89 17 0.70 0.66 0.75
1990e99 14 0.76 0.68 0.83
2000þ 6 0.83 0.72 0.92
2.66 *
Combined All 1950e69 1 0.26 0.17 0.35
1980e89 3 0.58 0.39 0.76
1990e99 6 0.80 0.67 0.90
2000þ 8 0.81 0.75 0.87
29.76 ***
All US 1950e69 2 0.59 0.45 0.72
1970e79 5 0.68 0.57 0.78
1980e89 14 0.62 0.53 0.69
1990e99 8 0.812 0.75 0.87
2000þ 4 0.792 0.69 0.88
5.52 ***
All Europe 1950e69 2 0.25 0.17 0.34
1970e79 2 0.72 0.61 0.82
1980e89 4 0.51 0.34 0.68
1990e99 6 0.61 0.54 0.67
2000þ 7 0.75 0.66 0.82
18.29 ***
All China 1970e79 3 0.64 0.56 0.72
1980e89 5 0.64 0.51 0.75
1990e99 1 0.84 0.80 0.88
2000þ 3 0.89 0.84 0.94
13.82 ***
All Japan 1970e79 2 0.63 0.42 0.82
1980e89 7 0.70 0.53 0.84
1990e99 3 0.90 0.85 0.94
2000þ 1 0.92 0.90 0.95
7.21 ***
All Other 1970e79 5 0.60 0.51 0.69
1980e89 5 0.57 0.38 0.75
1990e99 8 0.72 0.63 0.80
2000þ 3 0.86 0.76 0.93
5.82 ***
Note that lines with no available blocks are omitted, and that signiﬁcant heterogeneity by the factor studied (period, sex or region) is indicated by (*) p < 0.1, *p < 0.05,
**p < 0.01 and ***p < 0.001. NS indicates p  0.1.
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P.N. Lee et al. / Regulatory Toxicology and Pharmacology 74 (2016) 12e2218Table 1 gives the breakdown of reasons for rejection for the 3463
papers rejected.3.2. Data available
After eliminating overlapping data blocks or those from which
none of the three proportions could be calculated, there are 219
relevant sex- and period-speciﬁc blocks of data, based on 157
publications. Of these, 65 blocks relate to males, 100 to females and
54 to sexes combined. Numbers of blocks are 7, 7, 24, 54, 69 and 58
for, respectively, 1950e59, 60e69, 70e79, 80e89, 90e99, and
2000þ. 56 of the blocks relate to the USA, with 60 from Europe, 31
from China, 30 from Japan, and 42 from other or multi-country
studies.
The Supplementary ﬁle shows the data analysed, by block sorted
onmidpoint of time period within country. For each block, it shows
the study reference, sex, range of years and location, as well as the
proportions of AdC and number of cases for each of the three an-
alyses (P1, P2 and P3). It also provides details of data entered but
not considered due to overlap. Overall, there are 176 proportions
available for analysis 1, 182 for analysis 2 and 100 for analysis 3.3.3. Results for analysis 1
Table 2 gives the results of the random effects meta-analyses
based on P1 (AdC as a proportion of AdC þ SqCC). The analyses
are equivalent to a test of variation in the AdC/SqCC ratio.
Overall, P1 is estimated as 0.80 (95% CI 0.77e0.82). It is some-
what higher in females than males, and shows some evidence of
variation by region, with the highest values seen in Japan and theFig. 1. Random-effects estimates of the proportion of AdC, by period. The ﬁgure shows how
periods drawn from 157 publications. The number of AdC cases is expressed as a proportio
proportion of the four main types combined (AdC, LgCC, SqCC and SmCC) in analysis 3. Thelowest in Europe. Overall, there is a very clear tendency (p < 0.001)
for P1 to vary by time group. Based on the ﬁve group classiﬁcation,
the estimate of P1 increased monotonically with time, rising from
0.63 (95% CI 0.46e0.78) for the ﬁrst period, 1950e69, to 0.87 (95%
CI 0.85e0.90) for the ﬁnal period, 2000þ. Compared to 1950e69,
the AdC/SqCC ratio was higher by a factor 1.67 in 1970e79, 1.97 in
1980e89, 2.35 in 1990e99 and 3.93 in 2000 onwards. Signiﬁcant
(p < 0.05) evidence of variation in P1 by time is seen for males,
females and sexes combined, andwithin regions, with, in each case,
the estimate higher in the ﬁnal period, 2000þ, than in the earliest
period for which results were available. The rise with period is
monotonic in all the ﬁve regions, except for Japan. Additional an-
alyses (results not shown) showed no signiﬁcant variation ac-
cording to whether the deﬁnition of AdC included or excluded
BALC.3.4. Results for analysis 2
Table 3 gives the corresponding results based on P2 (AdC as a
proportion of all cases). Though the values of P2 are less than for P1,
the conclusions are similar, with estimates higher for females and
for Japan, and rising substantially by time, from 0.36 (95% CI
0.25e0.47) for 1950e69 to 0.67 (95% CI 0.63e0.72) for 2000þ. The
rise is evident in each sex, and within each region, most clearly for
USA and Europe.3.5. Results for analysis 3
Table 4 gives the meta-analysis results based on P3 (AdC as a
proportion of the four major types). While the overall estimate ofthe proportion of AdC has increased over time, comparing estimates derived for ﬁve
n of AdC þ SqCC cases in analysis 1, as a proportion of all cases in analysis 2, and as a
three analyses are shown slightly offset, so that the error bars are more clearly visible.
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be drawn are similar. The rise in the proportion, from 0.41 (95% CI
0.21e0.63) for 1950e59 to 0.82 (95% CI 0.77e0.86) for 2000þ,
based on all the available estimates, is very clearly evident in all ﬁve
regions, as well as in both sexes.
3.6. Comparison of results for the three analyses
Fig. 1 illustrates the clear time trend for all three analyses.
3.7. Trends in other cell types
Table 5 gives reduced results of meta-analyses for other indi-
vidual cell types as a proportion of total cases. While there is some
evidence of a decline over time in the proportion of SqCC, there is
no clear evidence of a trend for other cell types. The proportion of
SmCC appears to have been quite constant for many years.
4. Discussion
Based on a substantial amount of data drawn from 157 publi-
cations, a clear tendency for the proportion of AdC in never
smokers to increase over time has been demonstrated. This isTable 5
Random-effects meta-analyses of the proportion of other cell types out of the total cases
Cell type Period Blocks Mean
Squamous All 148 0.15
1950e59 3 0.30
1960e69 5 0.17
1970e79 15 0.21
1980e89 39 0.18
1990e99 50 0.13
2000þ 36 0.10
Small All 129 0.05
1950e59 3 0.18
1960e69 3 0.06
1970e79 14 0.05
1980e89 34 0.05
1990e99 42 0.05
2000þ 33 0.04
Large and undifferentiated All 80 0.06
1950e59 2 0.01
1960e69 2 0.16
1970e79 10 0.08
1980e89 28 0.10
1990e99 22 0.03
2000þ 16 0.03
Other (1) All 73 0.10
1950e59 2 0.20
1960e69 1 0.08
1970e79 10 0.06
1980e89 22 0.08
1990e99 22 0.14
2000þ 16 0.10
Other (2) All 148 0.24
1950e59 3 0.37
1960e69 5 0.32
1970e79 15 0.28
1980e89 39 0.26
1990e99 50 0.23
2000þ 36 0.20
Analyses are for all regions and sexes.
Other (1) is other than the 4 main types. Other (2) is other than AdC and SqCC.
Signiﬁcant heterogeneity by period is indicated by (*) p < 0.1, *p < 0.05, **p < 0.01 andevident in both sexes and not speciﬁc to any particular region. It can
clearly be seen whether expressed as a proportion of AdC þ SqCC,
all lung cancer cases, or the four major types combined. Comparing
data for 1950e69 with the most recent data, for the period 2000þ,
the rise is equivalent to about a 4-fold increase in the AdC/SqCC
ratio.
Though the data analysed here are based on proportions, rather
than rates, and concern a somewhat different time range, the
ﬁndings are consistent with our earlier paper (Lee and Forey, 2013),
where we indirectly estimated absolute lung cancer mortality rates
in never smokers by histological type based on a systematic review.
These estimates (reproduced in Table 6) were indirectly derived
based on relative risk estimates from studies published in the 20th
century, coupled with WHO mortality data for age 70e74 for the
relevant country and period. Likewise, these ﬁndings are consistent
with those of Samet et al. (2009), who reported that in men the rate
of AdC of the lung was increasing over time, and the rate of SqCC
decreasing, regardless of their smoking status.
It has been suggested that the increasing use of ﬁltered low tar
cigarettes is associatedwith an increase in the risk of AdC and in the
AdC/SqCC ratio (Burns et al., 2011; Thun et al., 1997). However, this
hypothesis is difﬁcult to reconcile with a number of observations.
First, as stated in the introduction, it has been noted (Chen et al.,.
95% conﬁdence limits Between levels
Lower Upper Chisq per DF p
0.13 0.16
0.22 0.40
0.07 0.30
0.14 0.29
0.14 0.21
0.11 0.16
0.08 0.12
8.65 ***
0.04 0.06
0.23 0.60
0.00 0.16
0.03 0.07
0.04 0.07
0.03 0.07
0.03 0.06
0.50 NS
0.05 0.08
0.03 0.09
0.08 0.27
0.04 0.12
0.07 0.13
0.02 0.05
0.01 0.05
6.52 ***
0.08 0.13
0.12 0.30
0.00 0.22
0.02 0.12
0.06 0.12
0.09 0.18
0.06 0.15
2.33 *
0.22 0.26
0.21 0.54
0.13 0.56
0.19 0.37
0.22 0.29
0.20 0.27
0.17 0.24
1.90 (*)
***p < 0.001. NS indicates p  0.1.
Table 6
Increase in the ratio of AdC to SqCC rates in never smokers.a
Period Nb SqCC rate (95%
CI)c
AdC rate (95% CI)d Ratioe Relative ratio
1930e60 11 7.6 (5.1e11.2) 6.9 (4.6e10.4) 0.91 1.00
1961e70 8 12.6 (6.0e26.7) 17.0 (12.6e22.9) 1.35 1.49
1971e80 18 12.7 (8.6e18.9) 18.1 (11.8e27.8) 1.43 1.57
1981e90 40 10.2 (7.6e13.6) 29.0 (23.4e35.8) 2.84 3.13
1991e99 4 11.6 (7.3e18.4) 33.9 (17.6e65.3) 2.92 3.22
a Adapted from Table 10 of Lee and Forey, 2013, based on indirectly estimated
rates per 100,000 per year for age 70e74 years for sexes combined.
b Number of independent estimates combined in meta-analysis.
c There was no signiﬁcant between-period variation in the rates of SqCC.
d There was signiﬁcant (p < 0.01) between-period variation in the rates of AdC.
e AdC/SqCC ratio.
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consumption (which did not start until after 1970) did not precede
the observed increases in AdC rates and the AdC/SqCC ratio,
consistent with our ﬁndings, as can readily be seen in Fig. 1. Also,
the epidemiological evidence has clearly shown that the switch
from high tar plain cigarettes to reduced tar ﬁlter cigarettes has
been accompanied by some decrease in the risk of overall lung
cancer and of SqCC, with no indication of any increase in the risk of
AdC. These ﬁndings are evident both frommeta-analyses of studies
published in the last century (Lee, 2001; Lee et al., 2012) and in
more recent studies (Brooks et al., 2005; Marugame et al., 2004;
Papadopoulos et al., 2011), and cannot be explained by failure to
adjust for differences in cigarette consumption between smokers of
the different products (Lee and Sanders, 2004). These observations
are inconsistent with the presumption that changes in cigarette
design and composition have increased the risk of AdC, although
theymay have contributed to some of the increase in the AdC/SqCC
ratio by decreasing the risk of SqCC.
The clear increase we observed in the AdC/SqCC ratio in never
smokers cannot logically arise from changes in cigarette design.
Though such analyses cannot exclude the possibility that changes
in cigarettes may have affected the distribution in smokers, they do
add strength to the argument that the overall rise in the AdC/SqCC
ratio is to an important extent due to other reasons.
This view is reinforced by the apparently strong evidence that
changes in the histological classiﬁcation of lung tumours may have
affected the reported AdC/SqCC ratio. Table 7 summarizes evidence
from six studies involving over 100 cases where the diagnosis of
histological type made some years earlier was later reviewed. As
can be seen, four reported a highly signiﬁcant increase (p < 0.001)
in the number of cases assigned to AdC, though two reported little
change. As noted in the introduction, there are also many studies
that have found little or no change in the percentage of lung cancers
that are AdC, when reviewing, using standard criteria, casesTable 7
Summary of results for AdC from studies of over 100 cases reviewing diagnosis of histol
Location Timing Num
Original Reviewa Agre
Connecticut, USA (Yesner et al., 1973) 1953e69 1967e69 63
New Hampshire and Vermont, USA (Greenberg et al., 1984) 1973e76 1983 118
New Mexico, USA (Butler et al., 1987) 1980e81 1986 75
Various states, USA (Fontham et al., 1991) 1985e88 1990 237
Turin, Italy (Campobasso et al., 1993) 1989 1992 104
Missouri, USA (Brownson et al., 1995) 1986e92 1994 256
Total 853
a Taken as one year before the date of publication, where the timing of the review wa
b Ratio of reviewer total to original total. Signiﬁcance level based on McNemar test. Rela
1.29, 1.15, 1.38, 2.51 and 2.81 for the six blocks in Table 7.occurring over a long time period. The longest period studied was
in the study by Beard et al. (1985) who reported percentages of 22%,
20%, 21% and 29% in men for 1935e54, 1955e64, 1965e74 and
1975e79, and 18%, 22% and 17% in females for 1935e64, 1965e74
and 1975e79. While the percentages were relatively stable, rates
rose sharply over the period in both sexes. Barsky et al. (1994)
similarly reported little or no change over time in the percentage of
AdC in sexes combined between 1961 and 65 (19.6%) and 1986e90
(23.4%).
Could other aspects of tobacco smoke exposure have affected
the time trend in the proportion of AdC? One possibility that might
be considered is changes in environmental tobacco smoke (ETS)
exposure. However, there is little evidence that the association of
ETS with lung cancer risk varies materially by lung cancer type,
with a recent meta-analysis (P.N. Lee personal communication)
reporting non-signiﬁcantly different RRs of 1.44 (95% 1.15e1.80) for
SqCC and 1.33 (1.17e1.51) for AdC based on evidence from,
respectively, 24 and 30 studies in never smokers, so changes in ETS
exposure seems unlikely to be relevant.
Another possibility is that our analyses in never smokers might
be biased by the inclusion of misclassiﬁed current or former
smokers, with the results reﬂecting changes in cigarette design.
While there is clear evidence of such misclassiﬁcation, there is
dispute about its level (Boffetta, 2002; Lee and Forey, 1995). Even
assuming the high rate of misclassiﬁcation rate suggested (Lee
et al., 2001), with 2.5% of average lung cancer risk ever smokers
misclassiﬁed as never smokers, one would require an extremely
large shift in the proportion of AdC in the misclassiﬁed smokers.
Thus assuming for example that 70% of the population were true
ever smokers, and that their lung cancer RR is 5.50 as indicated by
recent meta-analyses (Lee et al., 2012), the lung cancer risk in
observed never smokers would only be increased by a factor
(70  0.025  5.5 þ 30)/(70  0.025 þ 30) ¼ 39.625/31.75 ¼ 1.25.
Given that the proportion of AdC has risen 4-fold in observed
never smokers, and that changes in cigarette design do not affect
risk in true never smokers, the proportion of AdC would have to
have risen an estimated 16-fold in the misclassiﬁed ever smokers
for changes in cigarette design to be the whole explanation of the
rise, a rise much larger than that claimed for non-misclassiﬁed
smokers.
In considering the work reported here, some limitations should
be noted. First, our literature search may have been incomplete.
While it is difﬁcult, perhaps impossible in practice, to be sure that
all relevant studies have been found, the relatively large number of
studies that were found, and the clear pattern of results, suggests
that this is unlikely to have affected our main conclusion. The clear
pattern of results also suggests that any difﬁculties we had in data
extraction due to inadequate or incomplete reporting are likely to
be unimportant.ogical type of lung cancer.
ber of cases of AdC
ed Original only Reviewer only Original total Reviewer total Ratiob
17 68 80 131 1.64 (p < 0.001)
48 115 166 233 1.40 (p < 0.001)
32 29 107 104 0.97 (p > 0.1)
7 44 244 281 1.15 (p < 0.001)
6 109 110 213 1.94 (p < 0.001)
34 55 290 311 1.07 (p > 0.1)
144 420 997 1273 1.28 (p < 0.001)
s not provided.
tive frequencies of AdC to SqC for review to original diagnosis are, respectively, 2.15,
P.N. Lee et al. / Regulatory Toxicology and Pharmacology 74 (2016) 12e22 215. Conclusions
Among never smokers, the proportion of lung cancers that are
AdC has risen substantially since the middle of the 20th century.
This is evident in both sexes and all regions studied. Changes in the
histological diagnosis and classiﬁcation of lung tumours over time
are likely to have contributed to the rise. The rise in the AdC/SqCC
ratio in never smokers and inconsistencies between temporal
trends in lung cancer types and cigarette design modiﬁcations
argue against the hypothesis that increases in adenocarcinoma
arise from changes in cigarette design and composition.
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